Literature DB >> 25127684

Tolerance to the locomotor-activating effects of 3,4-methylenedioxymethamphetamine (MDMA) predicts escalation of MDMA self-administration and cue-induced reinstatement of MDMA seeking in rats.

Kevin T Ball1, Mylissa Slane2.   

Abstract

Pre-clinical studies of individual differences in addiction vulnerability have been increasing over recent years, but the amphetamine derivative 3,4-methylenedioxymethamphetamine (MDMA; ecstasy) has received relatively little attention in this regard. Previously, we reported large individual differences both in rats' initial behavioral response to experimenter-administered MDMA and their degree of behavioral sensitization to repeated administration. To determine whether these differences could predict subsequent patterns of MDMA-taking or -seeking behaviors we used the self-administration-extinction-reinstatement model to examine addiction-like behavior (i.e., escalation of MDMA self-administration and cue-induced reinstatement of MDMA seeking) in rats a priori characterized for either locomotor sensitization or tolerance to MDMA. Rats that developed tolerance to the locomotor-activating effects of MDMA had a significantly larger locomotor response to the first MDMA injection relative to rats that developed sensitization. Importantly, rats that developed tolerance subsequently displayed an escalation of MDMA self-administration over days, as well as clear cue-induced reinstatement of MDMA seeking following extinction. Conversely, rats that developed locomotor sensitization to MDMA subsequently maintained relatively stable levels of MDMA self-administration over days and showed no cue-induced reinstatement of MDMA seeking. These results show that differences in the level of psychomotor activation following acute and repeated MDMA administration can reliably predict two important addiction-like behaviors in rats, which may have implications in the prediction of compulsive MDMA use in humans.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cue; MDMA; Reinstatement; Self-administration; Sensitization; Tolerance

Mesh:

Substances:

Year:  2014        PMID: 25127684      PMCID: PMC4179501          DOI: 10.1016/j.bbr.2014.08.010

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  28 in total

Review 1.  The reinstatement model of drug relapse: history, methodology and major findings.

Authors:  Yavin Shaham; Uri Shalev; Lin Lu; Harriet de Wit; Jane Stewart
Journal:  Psychopharmacology (Berl)       Date:  2002-10-26       Impact factor: 4.530

2.  Electrophysiological and structural alterations in striatum associated with behavioral sensitization to (±)3,4-methylenedioxymethamphetamine (Ecstasy) in rats: role of drug context.

Authors:  K T Ball; C L Wellman; B R Miller; G V Rebec
Journal:  Neuroscience       Date:  2010-09-25       Impact factor: 3.590

3.  A comparison of the effects of different operant training experiences and dietary restriction on the reinstatement of cocaine-seeking in rats.

Authors:  Michele Bongiovanni; Ronald E See
Journal:  Pharmacol Biochem Behav       Date:  2007-12-23       Impact factor: 3.533

4.  The effects of response operandum and prior food training on intravenous nicotine self-administration in rats.

Authors:  Kelly J Clemens; Stephanie Caillé; Martine Cador
Journal:  Psychopharmacology (Berl)       Date:  2010-05-01       Impact factor: 4.530

Review 5.  Sensitization processes in drug addiction.

Authors:  Louk J M J Vanderschuren; R Christopher Pierce
Journal:  Curr Top Behav Neurosci       Date:  2010

6.  Differential involvement of prelimbic and infralimbic medial prefrontal cortex in discrete cue-induced reinstatement of 3,4-methylenedioxymethamphetamine (MDMA; ecstasy) seeking in rats.

Authors:  Kevin T Ball; Mylissa Slane
Journal:  Psychopharmacology (Berl)       Date:  2012-06-19       Impact factor: 4.530

7.  Individual differences in cocaine-induced locomotor sensitization in low and high cocaine locomotor-responding rats are associated with differential inhibition of dopamine clearance in nucleus accumbens.

Authors:  Jilla Sabeti; Greg A Gerhardt; Nancy R Zahniser
Journal:  J Pharmacol Exp Ther       Date:  2003-04       Impact factor: 4.030

Review 8.  Is ecstasy a drug of dependence?

Authors:  Louisa Degenhardt; Raimondo Bruno; Libby Topp
Journal:  Drug Alcohol Depend       Date:  2010-02-01       Impact factor: 4.492

9.  Tri-city study of Ecstasy use problems: a latent class analysis.

Authors:  Lawrence M Scheier; Arbi Ben Abdallah; James A Inciardi; Jan Copeland; Linda B Cottler
Journal:  Drug Alcohol Depend       Date:  2008-07-31       Impact factor: 4.492

10.  Low- and high-cocaine locomotor responding rats differ in reinstatement of cocaine seeking and striatal mGluR5 protein expression.

Authors:  Diana L Simmons; Bruce H Mandt; Christopher M C Ng; Toni L Richards; Dorothy J Yamamoto; Nancy R Zahniser; Richard M Allen
Journal:  Neuropharmacology       Date:  2013-08-22       Impact factor: 5.250

View more
  4 in total

1.  Yohimbine reinstates extinguished 3,4-methylenedioxymethamphetamine (MDMA; ecstasy) seeking in rats with prior exposure to chronic yohimbine.

Authors:  Kevin T Ball; Hanna Jarsocrak; Johanna Hyacinthe; Justina Lambert; James Lockowitz; Jordan Schrock
Journal:  Behav Brain Res       Date:  2015-08-01       Impact factor: 3.332

Review 2.  The serotonin 5-HT2C receptor and the non-addictive nature of classic hallucinogens.

Authors:  Clinton E Canal; Kevin S Murnane
Journal:  J Psychopharmacol       Date:  2016-11-15       Impact factor: 4.153

3.  Central Effects of the Designer Drug Mephedrone in Mice-Basic Studies.

Authors:  Anna Serefko; Gabriela Bielecka-Papierz; Sylwia Talarek; Aleksandra Szopa; Piotr Skałecki; Bernadeta Szewczyk; Maria Radziwoń-Zaleska; Ewa Poleszak
Journal:  Brain Sci       Date:  2022-01-30

4.  Poor sensitization of 50-kHz vocalization response to amphetamine predicts rat susceptibility to self-administration of the drug.

Authors:  Ewa Taracha; Ewelina Kaniuga; Edyta Wyszogrodzka; Adam Płaźnik; Roman Stefański; Stanisław J Chrapusta
Journal:  Psychopharmacology (Berl)       Date:  2016-06-02       Impact factor: 4.530

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.